Invention Grant
- Patent Title: Virulence attenuated bacteria for treatment of malignant solid tumors
-
Application No.: US15773524Application Date: 2016-11-17
-
Publication No.: US11166987B2Publication Date: 2021-11-09
- Inventor: Simon Ittig , Marlise Amstutz , Christoph Kasper , Guy R. Cornelis
- Applicant: Universität Basel
- Applicant Address: CH Basel
- Assignee: Universität Basel
- Current Assignee: Universität Basel
- Current Assignee Address: CH Basel
- Agency: Bozicevic, Field & Francis LLP
- Agent Shweta Chandra
- Priority: EP15195490 20151119
- International Application: PCT/EP2016/078084 WO 20161117
- International Announcement: WO2017/085233 WO 20170526
- Main IPC: A61K39/02
- IPC: A61K39/02 ; A61P35/00 ; A61K39/00 ; A61K39/112 ; A61K39/104 ; C12N15/74 ; A61K35/74
Abstract:
The present invention relates to recombinant virulence attenuated Gram-negative bacterial strains for use in a method of treating a malignant solid tumor in a subject.
Public/Granted literature
- US20190015497A1 Virulence Attenuated Bacteria For Treatment Of Malignant Solid Tumors Public/Granted day:2019-01-17
Information query
